<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Cooling Cap Therapy to Reduce Hair Loss during Chemotherapy  by </title>
      <link>https://padlet.com/eallen171/sml2nsae5rzj</link>
      <description>By Erin Allen</description>
      <language>en-us</language>
      <pubDate>2018-09-07 22:12:16 UTC</pubDate>
      <lastBuildDate>2024-07-29 07:47:32 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padlet-assets.s3.amazonaws.com/icons/Removelove.png</url>
      </image>
      <item>
         <title>DigniCap Scalp Cooling System </title>
         <author>eallen171</author>
         <link>https://padlet.com/eallen171/sml2nsae5rzj/wish/279035622</link>
         <description><![CDATA[<div><br>Sim, Y. <em>cancer.gov</em>. Retrieved September 7, 2018. Dignitana</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/308725373/6a9c0fc9f0c59de4d219905b8524b70a/DigniCap.jpg" />
         <pubDate>2018-09-07 22:18:16 UTC</pubDate>
         <guid>https://padlet.com/eallen171/sml2nsae5rzj/wish/279035622</guid>
      </item>
      <item>
         <title>Source: National Cancer Institute at the National Institutes of Health </title>
         <author>eallen171</author>
         <link>https://padlet.com/eallen171/sml2nsae5rzj/wish/279036781</link>
         <description><![CDATA[<div>National Cancer Institute at the National Institutes of Health, (July 21, 2017). <em>Fda clears wider use of cooling cap to reduce hair loss during chemotherapy</em>. Retrieved from <a href="https://www.cancer.gov/news-events/cancer-currents-blog/2017/fda-cooling-cap-chemotherapy">https://www.cancer.gov/news-events/cancer-currents-blog/2017/fda-cooling-cap-chemotherapy</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2018-09-07 22:37:10 UTC</pubDate>
         <guid>https://padlet.com/eallen171/sml2nsae5rzj/wish/279036781</guid>
      </item>
      <item>
         <title>DigniCap Pros</title>
         <author>eallen171</author>
         <link>https://padlet.com/eallen171/sml2nsae5rzj/wish/279036955</link>
         <description><![CDATA[<ul><li>Most patients experience hair loss of less than 50% or no hair loss as a result of treatment with the DigniCap Scalp Cooling System (“<em>DigniCapFrequently asked questions”,</em>n.d.).  </li><li>Women with breast cancer are experiencing less distress related to hair loss which is important as they already experience the emotional distress of other physical changes due to breast cancer (“<em>DigniCapFrequently asked questions”,</em>n.d.).  This therapy affords patients some dignity as well as a sense of control in a process where they often feel they lose both.  </li><li>This therapy provides hope to patients receiving chemotherapy for other forms of solid tumors, that they may experience the same benefits from the cooling cap therapy as breast cancer patients.</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2018-09-07 22:39:59 UTC</pubDate>
         <guid>https://padlet.com/eallen171/sml2nsae5rzj/wish/279036955</guid>
      </item>
      <item>
         <title>DigniCap Cons</title>
         <author>eallen171</author>
         <link>https://padlet.com/eallen171/sml2nsae5rzj/wish/279036962</link>
         <description><![CDATA[<ul><li>The total cost for the DigniCap Scalp Cooling System treatment ranges from $1,500 - $3,000 per patient and is not covered by insurance (National Cancer Institute at the National Institutes of Health, 2017).  Consequently, this treatment is not attainable for everyone.   </li><li>Treatment is not without side effects which include headaches, feeling light headed, neck and shoulder pain, and pain associated with wearing the device (“<em>DigniCapFrequently asked questions”,</em>n.d.).  </li><li>Scalp cooling treatment is not 100% effective at preventing hair loss (“<em>DigniCapFrequently asked questions”,</em>n.d.). </li><li>Time spent at the cancer center increases by 90-180 minutes as the cap must be worn before chemotherapy, during and after (“<em>DigniCapFrequently asked questions”,</em>n.d.).  </li><li>There are strict guidelines for hair care that must be followed during and after treatment with the DigniCapâScalp Cooling System (“<em>DigniCapFrequently asked questions”,</em>n.d.).  For instance, patients receiving treatment should avoid all hot hair tools and can only wash their hair 1-2 times per week using a paraben and sulfate free shampoo (“<em>DigniCapFrequently asked questions”,</em>n.d.).  These guidelines should continue to be observed for up to three months after their last chemotherapy session.  </li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2018-09-07 22:40:05 UTC</pubDate>
         <guid>https://padlet.com/eallen171/sml2nsae5rzj/wish/279036962</guid>
      </item>
      <item>
         <title>Opinion and Rationale</title>
         <author>eallen171</author>
         <link>https://padlet.com/eallen171/sml2nsae5rzj/wish/279036976</link>
         <description><![CDATA[<div>In my opinion, any treatment that can reduce or prevent hair loss with limited side effects in this patient population is well worth the investment.  Furthermore, if the benefits of scalp cooling therapy can be achieved in patients with other forms of solid tumors I am all for its use in those patient populations.  For most women their hair is a symbol of their femininity, individuality, personality, and is often tied to their feelings of attractiveness (Young &amp; Arif, 2016).  Breast cancer usually requires specific surgical procedures which can severely impact a woman’s body image in a negative way.  Sudden hair loss related to chemotherapy can further impact the patient’s body image and thus negatively impact their emotional well-being (Young &amp; Arif, 2016).  It is important for these patients to have a sense of control over what is happening to their bodies.  As a nurse it is my responsibility to preserve the patient’s dignity and self-worth and I believe that scalp cooling therapy will aid in the achievement of this directive.  </div>]]></description>
         <enclosure url="" />
         <pubDate>2018-09-07 22:40:24 UTC</pubDate>
         <guid>https://padlet.com/eallen171/sml2nsae5rzj/wish/279036976</guid>
      </item>
      <item>
         <title>Team Member Using the Clifton Strengths </title>
         <author>eallen171</author>
         <link>https://padlet.com/eallen171/sml2nsae5rzj/wish/279036997</link>
         <description><![CDATA[<ul><li>My top five strengths are Context, Individualization, Empathy, Focus and Discipline.  I sought team members that I felt would support my weaknesses, as well as team members that would enhance my strengths in order to build an effective team.  </li><li><strong>Angelica</strong>: Analytical (Strategic Thinking): Analytical team members partner well with those talented in context as they help keep things rational by seeking to understand the cause of an action, therefore I added Angelica to the team (“Student Action Items for Context”, n.d.).  </li><li><strong>Faith</strong>: Futuristic (Strategic Thinking): A futuristic team member partners well with context as they help bridge the past and with the present (“Student Action Items for Context” (n.d.).  These team members are inspirational to the group as a whole. which contributes to the success of the project (“CliftonStrengths  Quick Reference Card”, 2000). </li><li><strong>Carlee</strong>: Consistency (Executing): Groups can benefit from a team member strong in this area, as they set clear expectations for the group and hold each member equally accountable for achieving these expectations (“CliftonStrengths Quick Reference Card”, 2000). </li><li><strong>Mathew</strong>: Maximizer (Influencing): Every group should have a member with a talent as maximizer which is why I chose Mathew.  Maximizers are skilled at determining others talent areas and utilizing those strengths to build a stronger team (“CliftonStrengths Quick Reference Card”, 2000).    </li><li><strong>Pablo</strong>: Positivity (Relationship Building): Positivity is vital to team projects as they can become burdensome quickly.  People with a talent for positivity can help the team to stay excited and passionate about their long term goals for the project (“CliftonStrengths  Quick Reference Card”, 2000).  </li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2018-09-07 22:40:39 UTC</pubDate>
         <guid>https://padlet.com/eallen171/sml2nsae5rzj/wish/279036997</guid>
      </item>
      <item>
         <title>Summary</title>
         <author>eallen171</author>
         <link>https://padlet.com/eallen171/sml2nsae5rzj/wish/279037106</link>
         <description><![CDATA[<div>Hair loss during chemotherapy is one of the most stressful side effects for many patients.  While scalp cooling therapy has been utilized in Europe for decades to reduce hair loss in chemotherapy patients, widespread use in the United States is new.  Scalp cooling causes vasoconstriction which leads to a reduction in blood flow to the scalp and hair follicles.  This reduction in blood flow is thought to reduce the amount of chemotherapy that reaches the hair follicles, thus reducing hair loss.  In 2015 the Food and Drug Administration (FDA) approved the DigniCap Scalp Cooling System for use during chemotherapy to reduce the severity of hair loss in breast cancer patients.  Recently, the FDA expanded the use of the cooling cap for patients receiving appropriate chemotherapy treatment regimens for any solid tumors.  Consequently, expanding the potential hair loss reduction benefits to other cancer patients.  </div><div>The DigniCap Scalp Cooling System involves the circulation of a cool liquid regulated by a machine, into an inner fitted cap that the patient wears throughout the entire chemotherapy process.  The outer cap is made from neoprene, thus insulting the cool liquid circulating inside the inner cap.  Side effects include pain in the neck and shoulders, pain from the form fitting cap and headache directly related to the cold therapy.  </div><div>In the study that granted the DigniCap FDA approval, 62 out of 101 participants lost less then 50% of their hair, while 5 out of 101 participants experienced no hair loss.  An expanded study involving 226 participants undergoing chemotherapy for different types of solid tumors as the basis for the FDA expansion.  In this study 65% of the patients experienced mild to no hair loss. The type of chemotherapy patients receive does impact the treatment effects of the DigniCap therapy. </div><div>The Paxman Scalp Cooling System is also under consideration for approval by the FDA and could be the second approved scalp cooling device in the United States.  Of the 48 participants that received scalp cooling therapy from the Paxman Scalp Cool System during chemotherapy, 5 experienced no hair loss, while 43 experienced a 50% hair loss.  </div><div> </div>]]></description>
         <enclosure url="" />
         <pubDate>2018-09-07 22:42:08 UTC</pubDate>
         <guid>https://padlet.com/eallen171/sml2nsae5rzj/wish/279037106</guid>
      </item>
      <item>
         <title>References</title>
         <author>eallen171</author>
         <link>https://padlet.com/eallen171/sml2nsae5rzj/wish/279652003</link>
         <description><![CDATA[<div>Clifton Strengths Quick Reference Card (2000). Retrieved from <a href="http://www.strengthsquest.com/home/default.aspx">http://www.strengthsquest.com/home/default.aspx</a><br><br></div><div><em>DigniCapFrequently asked questions. </em>(n.d.).Retrieved from<a href="https://dignicap.com/faq/">https://dignicap.com/faq/</a><br><br>DigniCap (producer). (2015). <em>What is scalp cooling?</em>[video]. Available from https://dignicap.com/how-it-works/<br><br></div><div>National Cancer Institute at the National Institutes of Health, (July 21, 2017). <em>Fda clears wider use of cooling cap to reduce hair loss during chemotherapy</em>. Retrieved from <a href="https://www.cancer.gov/news-events/cancer-currents-blog/2017/fda-cooling-cap-chemotherapy">https://www.cancer.gov/news-events/cancer-currents-blog/2017/fda-cooling-cap-chemotherapy</a><br><br>Sim, Y. <em>cancer.gov</em>. Retrieved September 7, 2018. Dignitana</div><div>Student action items for context. (n.d.). Retrieved from <a href="https://www.strengthsquest.com/home/action.aspx">https://www.strengthsquest.com/home/action.aspx</a><br><br></div><div>Young, A, &amp; Arif, A. (2016). The use of scalp cooling for chemotherapy-induced hair loss. <em>British Journal of Nursing, 25</em>(10), S22-S27. Retrieved from https://info.britishjournalofnursing.com</div>]]></description>
         <enclosure url="" />
         <pubDate>2018-09-10 23:50:59 UTC</pubDate>
         <guid>https://padlet.com/eallen171/sml2nsae5rzj/wish/279652003</guid>
      </item>
      <item>
         <title>What is Scalp Cooling?</title>
         <author>eallen171</author>
         <link>https://padlet.com/eallen171/sml2nsae5rzj/wish/280384852</link>
         <description><![CDATA[<div>DigniCap (producer). (2015). <em>What is scalp cooling? </em>[video]. Available from https://dignicap.com/how-it-works/ </div>]]></description>
         <enclosure url="https://www.youtube.com/watch?v=5yizg1ya3j0" />
         <pubDate>2018-09-12 14:51:23 UTC</pubDate>
         <guid>https://padlet.com/eallen171/sml2nsae5rzj/wish/280384852</guid>
      </item>
   </channel>
</rss>
